James A. Schoeneck
2019 - FibroGen
In 2019, James A. Schoeneck earned a total compensation of $5.2M as Interim Chief Executive Officer at FibroGen.
Compensation breakdown
| Option Awards | $2,329,934 |
|---|---|
| Salary | $564,103 |
| Stock Awards | $2,347,008 |
| Other | $6,920 |
| Total | $5,247,964 |
Schoeneck received $2.3M in stock awards, accounting for 45% of the total pay in 2019.
Schoeneck also received $2.3M in option awards, $564.1K in salary and $6.9K in other compensation.
Rankings
In 2019, James A. Schoeneck's compensation ranked 2,062nd out of 13,971 executives tracked by ExecPay. In other words, Schoeneck earned more than 85.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,062 out of 13,971 | 85th |
Division Manufacturing | 750 out of 5,701 | 87th |
Major group Chemicals And Allied Products | 227 out of 2,200 | 90th |
Industry group Drugs | 184 out of 1,886 | 90th |
Industry Pharmaceutical Preparations | 133 out of 1,398 | 91st |
Source: SEC filing on April 23, 2020.
Schoeneck's colleagues
We found five more compensation records of executives who worked with James A. Schoeneck at FibroGen in 2019.
2019
Thomas Neff
FibroGen
Chief Executive Officer
2019
K Yu
FibroGen
Chief Medical Officer
2019
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
2019
Christine Chung
FibroGen
Senior Vice President, China Operations
2019
Pat Cotroneo
FibroGen